{"id":59043,"date":"2024-03-14T22:01:18","date_gmt":"2024-03-14T21:01:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"modified":"2024-03-14T22:01:18","modified_gmt":"2024-03-14T21:01:18","slug":"veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","title":{"rendered":"Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum"},"content":{"rendered":"
\n

CHICAGO–(BUSINESS WIRE)–#healthIT<\/a>—Veradigm Inc.<\/a> (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm Interim Chief Executive Officer and board member, Lee Westerfield, Interim Chief Financial Officer, and Will Manidis Co-Founder of ScienceIO will participate in a fireside chat at the KeyBanc Capital Markets Life Science & MedTech Investor Forum on Tuesday, March 19th, 2024 at 12:00 PM EDT.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe webcast will be available in the investor section of the company’s website at investor.veradigm.com<\/a>, with an archived version accessible later that same day.<\/p>\n

\nAbout Veradigm\u00ae<\/b><\/p>\n

\nVeradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, <\/i>visit www.veradigm.com<\/a>, or find Veradigm on LinkedIn<\/a>, Facebook<\/a>, Twitter<\/a>, and YouTube<\/a>.<\/p>\n

\n\u00a9 2024 Veradigm Inc. and\/or its affiliates. All rights reserved.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors:<\/span>
Jenny Gelinas
\n
312-506-1237
\n
jenny.gelinas@veradigm.com<\/a><\/p>\n

\nMedia:<\/span>
Concetta Rasiarmos
\n
312-447-2466
\n
concetta.rasiarmos@veradigm.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHICAGO–(BUSINESS WIRE)–#healthIT—Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm Interim Chief Executive Officer and board member, Lee Westerfield, Interim Chief Financial Officer, and Will Manidis Co-Founder of ScienceIO will participate in a fireside chat at the KeyBanc Capital Markets Life Science & MedTech … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59043","6":"format-standard","7":"category-industry"},"yoast_head":"\nVeradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO–(BUSINESS WIRE)–#healthIT—Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm Interim Chief Executive Officer and board member, Lee Westerfield, Interim Chief Financial Officer, and Will Manidis Co-Founder of ScienceIO will participate in a fireside chat at the KeyBanc Capital Markets Life Science & MedTech ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-14T21:01:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240314344298\/en\/1867052\/22\/VeradigmR-logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum\",\"datePublished\":\"2024-03-14T21:01:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"},\"wordCount\":210,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240314344298\\\/en\\\/1867052\\\/22\\\/VeradigmR-logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\",\"name\":\"Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240314344298\\\/en\\\/1867052\\\/22\\\/VeradigmR-logo.jpg\",\"datePublished\":\"2024-03-14T21:01:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240314344298\\\/en\\\/1867052\\\/22\\\/VeradigmR-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240314344298\\\/en\\\/1867052\\\/22\\\/VeradigmR-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","og_locale":"en_US","og_type":"article","og_title":"Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Pharma Trend","og_description":"CHICAGO–(BUSINESS WIRE)–#healthIT—Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm Interim Chief Executive Officer and board member, Lee Westerfield, Interim Chief Financial Officer, and Will Manidis Co-Founder of ScienceIO will participate in a fireside chat at the KeyBanc Capital Markets Life Science & MedTech ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","og_site_name":"Pharma Trend","article_published_time":"2024-03-14T21:01:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240314344298\/en\/1867052\/22\/VeradigmR-logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum","datePublished":"2024-03-14T21:01:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"wordCount":210,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240314344298\/en\/1867052\/22\/VeradigmR-logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","url":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","name":"Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240314344298\/en\/1867052\/22\/VeradigmR-logo.jpg","datePublished":"2024-03-14T21:01:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240314344298\/en\/1867052\/22\/VeradigmR-logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240314344298\/en\/1867052\/22\/VeradigmR-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/veradigm-to-participate-in-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59043","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59043"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59043\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59043"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59043"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}